Dr Rylan Cox – Research Fellow and Co-Founder
I'm excited by the potential of our projects to deliver real-world impact, including reducing water use and carbon emissions.
An introduction to BBNet member – Rylan Cox
Hello, I’m Dr Rylan Cox, a Research Fellow at Cranfield University and Co-Founder of C-Source Renewables. My background is in mechanical engineering, with an EngD focused on using continuous flow systems to convert waste into higher-value chemicals.
What work are you doing in the bioeconomy space?
Academically, I focus on valorising food waste feedstocks into platform chemicals using intensified continuous flow technologies. These lab-based feasibility studies support techno-economic modelling and business case development. Commercially, through EcoLoaf and EcoSpud, we produce glucose syrups from surplus bread and potato waste for use across chemical, fuel, cosmetic, and food sectors. We’ve validated these with partners in the UK and Europe, contributing to a more circular and sustainable bioeconomy.
What are you most excited about right now in your work?
I’m most excited by the potential of our projects to deliver real-world impact. One ongoing project could significantly reduce water use and carbon emissions. On the business side, growing industry interest in our glucose syrups demonstrates their scalability and relevance.
What do you see as the long-term potential and impact of your research?
My research aims to enhance the economic feasibility of bioprocesses using low-value feedstocks via process intensification. EcoLoaf and EcoSpud, in particular, could disrupt conventional glucose supply chains and support decentralised, sustainable production models.
What got you interested in this area of research?
Though trained as an engineer, I’ve long been drawn to biotechnology. My undergraduate project focused on biobased insulation, and my Master’s thesis explored novel microalgae cultivation. These experiences revealed both the technical challenges and the global importance of biotechnological innovation.
What concerns do you have about current UK policy?
A major concern is the lack of strategic investment in biotechnology scale-up. The article “Don’t Fail to Scale!” captures the risk of losing innovations due to insufficient infrastructure. To address this, the UK must expand regional biomanufacturing facilities and targeted funding for translational research.
What has been your favourite collaboration so far?
Working with Britvic–Carlsberg through BBNet’s BIV scheme has been a highlight. It offered insights into corporate innovation and fostered valuable academic–industry connections—plus some of the best-smelling samples I’ve encountered!
What is your favourite thing about BBNet events?
BBNet events have provided inclusive networking platforms and fostered interdisciplinary dialogue, enabling collaborations and widening the impact of my work.
If anyone is interested in collaborating using continuous flow for biotechnology or looking to use bread or potato-based feedstocks for their commercial process I’d be more than happy to have a chat!
